Jocil [JOCIL] vs Grauer & Weil [GRAUWEIL] Detailed Stock Comparison

Jocil
NSE
Loading...

Grauer & Weil
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Jocil wins in 7 metrics, Grauer & Weil wins in 12 metrics, with 0 ties. Grauer & Weil appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Jocil | Grauer & Weil | Better |
---|---|---|---|
P/E Ratio (TTM) | 139.44 | 26.73 | Grauer & Weil |
Price-to-Book Ratio | 0.69 | 4.48 | Jocil |
Debt-to-Equity Ratio | 0.00 | 1.26 | Jocil |
PEG Ratio | N/A | 37.25 | N/A |
EV/EBITDA | 15.96 | 20.89 | Jocil |
Profit Margin (TTM) | 0.13% | 13.35% | Grauer & Weil |
Operating Margin (TTM) | 0.94% | 18.36% | Grauer & Weil |
EBITDA Margin (TTM) | 0.94% | 18.36% | Grauer & Weil |
Return on Equity | 0.49% | 16.73% | Grauer & Weil |
Return on Assets (TTM) | 0.35% | 12.23% | Grauer & Weil |
Free Cash Flow (TTM) | $16.40M | $999.80M | Grauer & Weil |
Dividend Yield | 0.94% | 1.05% | Grauer & Weil |
1-Year Return | -26.74% | -12.16% | Grauer & Weil |
Price-to-Sales Ratio (TTM) | 0.16 | 3.74 | Jocil |
Enterprise Value | $917.39M | $36.79B | Grauer & Weil |
EV/Revenue Ratio | 0.10 | 3.27 | Jocil |
Gross Profit Margin (TTM) | 18.46% | 41.05% | Grauer & Weil |
Revenue per Share (TTM) | $1,012 | $25 | Jocil |
Earnings per Share (Diluted) | $1.15 | $3.47 | Grauer & Weil |
Beta (Stock Volatility) | -0.10 | 0.28 | Jocil |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Jocil vs Grauer & Weil Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Jocil | 0.25% | -0.76% | -2.40% | -5.35% | -1.86% | -21.48% |
Grauer & Weil | 0.11% | -1.67% | -9.55% | 9.20% | 3.21% | -10.50% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Jocil | -26.74% | -18.02% | -19.40% | 20.06% | -15.47% | 525.21% |
Grauer & Weil | -12.16% | 39.87% | 111.69% | 450.88% | 1,078.97% | 750.95% |
Performance & Financial Health Analysis: Jocil vs Grauer & Weil
Metric | JOCIL | GRAUWEIL |
---|---|---|
Market Information | ||
Market Cap | ₹1.42B | ₹42.05B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 13,118 | 141,218 |
90 Day Avg. Volume | 6,715 | 163,561 |
Last Close | ₹160.14 | ₹94.30 |
52 Week Range | ₹132.40 - ₹236.00 | ₹78.00 - ₹120.00 |
% from 52W High | -32.14% | -21.42% |
All-Time High | ₹319.80 (Jul 26, 2021) | ₹204.80 (Feb 26, 2024) |
% from All-Time High | -49.92% | -53.96% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.14% | -0.04% |
Quarterly Earnings Growth | 0.08% | -0.14% |
Financial Health | ||
Profit Margin (TTM) | 0.00% | 0.13% |
Operating Margin (TTM) | 0.01% | 0.18% |
Return on Equity (TTM) | 0.00% | 0.17% |
Debt to Equity (MRQ) | 0.00 | 1.26 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹231.50 | ₹20.72 |
Cash per Share (MRQ) | ₹57.03 | ₹11.87 |
Operating Cash Flow (TTM) | ₹-125,680,000 | ₹1.68B |
Levered Free Cash Flow (TTM) | ₹10.20M | ₹1.57B |
Dividends | ||
Last 12-Month Dividend Yield | 0.94% | 1.05% |
Last 12-Month Dividend | ₹1.50 | ₹1.00 |
Valuation & Enterprise Metrics Analysis: Jocil vs Grauer & Weil
Metric | JOCIL | GRAUWEIL |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 139.44 | 26.73 |
Forward P/E | N/A | 37.25 |
PEG Ratio | N/A | 37.25 |
Price to Sales (TTM) | 0.16 | 3.74 |
Price to Book (MRQ) | 0.69 | 4.48 |
Market Capitalization | ||
Market Capitalization | ₹1.42B | ₹42.05B |
Enterprise Value | ₹917.39M | ₹36.79B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 0.10 | 3.27 |
Enterprise to EBITDA | 15.96 | 20.89 |
Risk & Other Metrics | ||
Beta | -0.10 | 0.28 |
Book Value per Share (MRQ) | ₹231.50 | ₹20.72 |
Financial Statements Comparison: Jocil vs Grauer & Weil
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | JOCIL | GRAUWEIL |
---|---|---|
Revenue/Sales | ₹1.78B | ₹3.40B |
Cost of Goods Sold | ₹1.45B | ₹2.00B |
Gross Profit | ₹328.78M | ₹1.40B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹-303,000 | ₹237.20M |
EBITDA | ₹20.70M | ₹417.40M |
Pre-Tax Income | ₹5.84M | ₹343.50M |
Income Tax | ₹1.30M | ₹86.10M |
Net Income (Profit) | ₹4.54M | ₹257.40M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | JOCIL | GRAUWEIL |
---|---|---|
Cash & Equivalents | ₹252.85M | ₹1.08B |
Total Current Assets | ₹2.36B | ₹9.36B |
Total Current Liabilities | ₹789.85M | ₹2.97B |
Long-Term Debt | ₹0 | ₹37.30M |
Total Shareholders Equity | ₹2.06B | ₹9.39B |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | ₹369.19M | ₹2.47B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | JOCIL | GRAUWEIL |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | JOCIL | GRAUWEIL |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 13,118 | 141,218 |
Average Daily Volume (90 Day) | 6,715 | 163,561 |
Shares Outstanding | 8.88M | 453.41M |
Float Shares | N/A | 127.47M |
% Held by Insiders | N/A | 0.72% |
% Held by Institutions | N/A | 0.00% |
Dividend Analysis & Yield Comparison: Jocil vs Grauer & Weil
Metric | JOCIL | GRAUWEIL |
---|---|---|
Last 12-Month Dividend | ₹1.50 | ₹1.00 |
Last 12-Month Dividend Yield | 0.94% | 1.05% |
3-Year Avg Annual Dividend | ₹2.00 | ₹0.58 |
3-Year Avg Dividend Yield | 0.95% | 0.45% |
3-Year Total Dividends | ₹6.00 | ₹1.73 |
Ex-Dividend Date | Sep 06, 2024 | Aug 06, 2025 |